• Something wrong with this record ?

Lab-on-a-screen-printed electrochemical cell for drop-volume voltammetric screening of flunitrazepam in untreated, undiluted alcoholic and soft drinks

F. Tseliou, P. Pappas, K. Spyrou, J. Hrbac, MI. Prodromidis,

. 2019 ; 132 (-) : 136-142. [pub] 20190305

Language English Country England, Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19034716

Flunitrazepam, also known as "Rohypnol" or "Rophy" among other trade and street names, is an extremely potent benzodiazepine that is prescribed to treat severe insomnia. Due to these attributes, flunitrazepam, when is surreptitiously administered to an alcoholic or soft drink, is associated with "drug-facilitated sexual assault". We report here for the first time, a low cost lab-on-a-screen-printed electrochemical cell (SPC) based on iron-sparked graphite working electrode modified with glucose oxidase (GOx) and glucose hydrogel droplets (GluHD) for the detection of flunitrazepam. Iron-spark modification increases the response of the sensor by ca. 3-fold compared with that of the plain electrode, while an in situ deoxygenation process, based on GOx-glucose enzyme reaction, depletes dissolved oxygen. As a result, the method enables interference free voltammetric measurements of the electro reduction of the nitro group of flunitrazepam at ca. -0.71 to -0.78 V vs. Ag printed pseudo reference electrode depending on the sample's matrix, and the detection of the drug at the sub-millimolar level. GOx/GluHD-FeSPC was directly applied to the drop-volume (∼60 μL) detection of flunitrazepam to a wide range of untreated and undiluted spiked samples (Pepsi cola®, Vodka, Whisky, Tequila, Gin, and Rum) of different acidity (pH 2.3-8.4), and alcohol content up to 40% v/v. Data demonstrate the excellent performance of the sensor for point-of-need screening of flunitrazepam and suggest that GOx/GluHD-FeSPC holds promise as an effective analytical tool to prevent phenomena of covert drug administration.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034716
003      
CZ-PrNML
005      
20191011085542.0
007      
ta
008      
191007s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bios.2019.03.001 $2 doi
035    __
$a (PubMed)30870640
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Tseliou, Fotini $u Department of Chemistry, University of Ioannina (UOI), Ioannina 45110, Greece.
245    10
$a Lab-on-a-screen-printed electrochemical cell for drop-volume voltammetric screening of flunitrazepam in untreated, undiluted alcoholic and soft drinks / $c F. Tseliou, P. Pappas, K. Spyrou, J. Hrbac, MI. Prodromidis,
520    9_
$a Flunitrazepam, also known as "Rohypnol" or "Rophy" among other trade and street names, is an extremely potent benzodiazepine that is prescribed to treat severe insomnia. Due to these attributes, flunitrazepam, when is surreptitiously administered to an alcoholic or soft drink, is associated with "drug-facilitated sexual assault". We report here for the first time, a low cost lab-on-a-screen-printed electrochemical cell (SPC) based on iron-sparked graphite working electrode modified with glucose oxidase (GOx) and glucose hydrogel droplets (GluHD) for the detection of flunitrazepam. Iron-spark modification increases the response of the sensor by ca. 3-fold compared with that of the plain electrode, while an in situ deoxygenation process, based on GOx-glucose enzyme reaction, depletes dissolved oxygen. As a result, the method enables interference free voltammetric measurements of the electro reduction of the nitro group of flunitrazepam at ca. -0.71 to -0.78 V vs. Ag printed pseudo reference electrode depending on the sample's matrix, and the detection of the drug at the sub-millimolar level. GOx/GluHD-FeSPC was directly applied to the drop-volume (∼60 μL) detection of flunitrazepam to a wide range of untreated and undiluted spiked samples (Pepsi cola®, Vodka, Whisky, Tequila, Gin, and Rum) of different acidity (pH 2.3-8.4), and alcohol content up to 40% v/v. Data demonstrate the excellent performance of the sensor for point-of-need screening of flunitrazepam and suggest that GOx/GluHD-FeSPC holds promise as an effective analytical tool to prevent phenomena of covert drug administration.
650    _2
$a alkoholické nápoje $x analýza $7 D000434
650    _2
$a anxiolytika $x analýza $7 D014151
650    _2
$a Aspergillus niger $x enzymologie $7 D001234
650    _2
$a biosenzitivní techniky $x metody $7 D015374
650    _2
$a sycené nápoje $x analýza $7 D002253
650    _2
$a elektrochemické techniky $x metody $7 D055664
650    _2
$a elektrody $7 D004566
650    _2
$a flunitrazepam $x analýza $7 D005445
650    _2
$a glukosa $x chemie $7 D005947
650    _2
$a glukosaoxidasa $x chemie $7 D005949
650    _2
$a grafit $x chemie $7 D006108
650    _2
$a lidé $7 D006801
650    _2
$a limita detekce $7 D057230
650    _2
$a kyslík $x chemie $7 D010100
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pappas, Periklis $u Department of Pharmacology, Faculty of Medicine, UOI, Ioannina, Greece.
700    1_
$a Spyrou, Konstantinos $u Department of Materials Science and Engineering, UOI, Ioannina 45110, Greece.
700    1_
$a Hrbac, Jan $u Department of Chemistry, Masaryk University, 62500 Brno, Czech Republic.
700    1_
$a Prodromidis, Mamas I $u Department of Chemistry, University of Ioannina (UOI), Ioannina 45110, Greece. Electronic address: mprodrom@uoi.gr.
773    0_
$w MED00006627 $t Biosensors & bioelectronics $x 1873-4235 $g Roč. 132, č. - (2019), s. 136-142
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30870640 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191011090002 $b ABA008
999    __
$a ok $b bmc $g 1451376 $s 1073266
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 132 $c - $d 136-142 $e 20190305 $i 1873-4235 $m Biosensors & bioelectronics $n Biosens Bioelectron $x MED00006627
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Archiving options